Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001419 |
---|---|
Receipt number | R000001731 |
Scientific Title | The efficacy and safety of autologous gamma/delta T cell transfer therapy for esophageal cancer |
Date of disclosure of the study information | 2008/10/08 |
Last modified on | 2019/04/16 10:57:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/10/08 19:09:01 | ||
2 | Update | 2009/03/03 10:17:30 | Email |
|
3 | Update | 2009/11/18 18:58:28 | Division name Address Address TEL |
|
4 | Update | 2009/11/18 18:58:51 | Recruitment status |
|
5 | Update | 2009/11/18 18:59:24 | UMIN ID1 |
|
6 | Update | 2009/11/18 19:07:30 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name |
|
7 | Update | 2009/12/22 14:29:45 | Recruitment status |
|
8 | Update | 2010/11/19 16:35:25 | Interventions/Control_1 Interventions/Control_1 |
|
9 | Update | 2011/04/07 12:24:28 | Last follow-up date |
|
10 | Update | 2012/10/10 09:31:49 | Target sample size |
|
11 | Update | 2014/10/08 15:14:16 | Last follow-up date |
|
12 | Update | 2016/11/25 14:36:03 | Recruitment status Anticipated trial start date Last follow-up date |
|
13 | Update | 2017/03/29 19:06:26 | Recruitment status |
|
14 | Update | 2018/01/30 17:58:43 | Email Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Tel1 Email1 |
|
15 | Update | 2018/04/19 11:15:27 | Last follow-up date |
|
16 | Update | 2019/04/16 10:57:36 | Recruitment status Date of IRB |